MSB 10.4% $1.49 mesoblast limited

ARDS Trial - From UPenn Principal Investigator, page-35

  1. 589 Posts.
    lightbulb Created with Sketch. 282
    hey bud @Sector ... I never said Lonza are a partner ... they are a very impressive operation engaged in a commercial deal to manufacture our stem cell products , to the very high standards that mesoblast would require using world best practices and approved by fda... very sorry I did not reply sooner but you are on my list of serial pests that are on ignore ... hope your CYP recovers for you .. cheers googala
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.49
Change
0.140(10.4%)
Mkt cap ! $1.701B
Open High Low Value Volume
$1.37 $1.54 $1.37 $23.10M 15.82M

Buyers (Bids)

No. Vol. Price($)
3 24758 $1.49
 

Sellers (Offers)

Price($) Vol. No.
$1.49 73626 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.